Primary Metastatic Renal Cell Carcinoma Treated With Immunecheckpoint Inhibitors and Cytoreductive Nephrectomy
Clinical trial NCT05941169 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05941169
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2030-04-01
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.